FDA одобрило иммунотерапию для части пациентов с раком прямой кишки — TIME
FDA одобрило иммунотерапию для части пациентов с раком прямой кишки — TIME UA.NEWS
Онкология
🎗️Лента новостей
Онкология
Женщина два года прикладывала подорожник к груди для лечения рака
Женщина два года прикладывала подорожник к груди для лечения рака NEWS.ru
🎗️
Онкология
«Услышать» рак на клеточном уровне: арт-объект, посвященный новым методам диагностики онкологических заболеваний
«Услышать» рак на клеточном уровне: арт-объект, посвященный новым методам диагностики онкологических заболеваний Правила жизни
Онкология
ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer - News-Medical
ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer News-Medical
Онкология
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026 Yahoo Finance
Онкология
Study: Recommending HPV vaccine at age 9 improves uptake
WASHINGTON — Children were twice as likely to begin and complete the HPV vaccine series at clinics that began recommending it at ages 9 and 10 instead of ages 11 and 12, according to findings presented at IDWeek. The HPV vaccine provides protection against 6 types of cancer. The CDC recommends HPV vaccination starting…
Онкология
Drug could help protect salivary glands during radiation treatment
Researchers at the University of Missouri have uncovered a promising way to protect saliva-producing glands from radiation damage that can make it difficult to eat, swallow, sleep and maintain oral hygiene.
Онкология
В Калининградском онкоцентре впервые удалили раковые опухоли лёгких через проколы
В Калининградском онкоцентре впервые удалили раковые опухоли лёгких через проколы kaliningradnews.online
Онкология
HER2-Positive Gastric Cancer Market Forecast to Reach US$2.05 Billion by 2035 as First-Line Treatment Options Expand | Report by DataM Intelligence
HER2-Positive Gastric Cancer Market Forecast to Reach US$2.05 Billion by 2035 as First-Line Treatment Options Expand | Report by DataM Intelligence markets.businessinsider.com
Онкология
Douglas Flora: Humanizing Cancer Care Through AI
Douglas Flora: Humanizing Cancer Care Through AI Oncodaily
Онкология
Study Finds Geographic Gaps in TNBC Trial Access Persist Across US
Study Finds Geographic Gaps in TNBC Trial Access Persist Across US Targeted Oncology
Онкология
Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer
Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer BioSpace
Онкология
The hidden role of a cancer treatment target could explain toxic side effects
Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, researchers from the MRC Laboratory of Medical Sciences (LMS), the University of Oxford and UCL have discovered a previously unknown role for Wee1 that could explain these effects.
